title: βIIPKC and εPKC isozymes as potential pharmacological targets in cardiac hypertrophy and heart failure.
authors.affiliation: Department of Chemical and Systems Biology, Stanford University School of Medicine, CCSR, Rm 3145A, 269 Campus Drive, Stanford, CA 94305-5174, USA.
authors.forename: Julio Cesar Batista
authors.initials: JC
authors.lastname: Ferreira
authors.forename: Patricia Chakur
authors.initials: PC
authors.lastname: Brum
authors.forename: Daria
authors.initials: D
authors.lastname: Mochly-Rosen
mesh_terms: D000818:Animals; D006332:Cardiomegaly / Q000188:drug therapy* / Q000201:enzymology; D006333:Heart Failure / Q000188:drug therapy* / Q000201:enzymology; D006801:Humans; D007527:Isoenzymes / Q000378:metabolism; D058990:Molecular Targeted Therapy; D009206:Myocardium / Q000201:enzymology*; D011493:Protein Kinase C / Q000378:metabolism*; D064546:Protein Kinase C beta; D051744:Protein Kinase C-epsilon / Q000378:metabolism*; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use
chemical_list: D007527:Isoenzymes; D047428:Protein Kinase Inhibitors; D011493:Protein Kinase C; D064546:Protein Kinase C beta; D051744:Protein Kinase C-epsilon